MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$7,461,960
Cash and cash
equivalents
$2,714,012
Amounts receivable and
prepaid expenses
$1,172,435
Long term prepaid
expenses
$717,508
Equity investment in bc
therapeutics
$554,448
Property and equipment,
net
$273,980
Intangible assets, net
$180,707
Total current assets
$11,348,407
Total non-current
assets
$1,726,643
Total assets
$13,075,050
Total liabilities and
shareholders equity
$13,075,050
Total shareholders
equity
$9,350,404
Total current
liabilities
$3,317,773
Total non-current
liabilities
$406,873
Accumulated deficit
-$119,953,129
Non-controlling interest
-$627,558
Accumulated other
comprehensive loss
-$138,684
Share capital of no par
value authorized...
$101,739,923
Trade payables
$2,128,915
Accrued expenses and
other payables
$1,188,858
Warrant liability
$406,873
Warrant reserve
$17,719,026
Share-based payment
reserved
$10,610,826
Back
Back
Balance Sheet
source: myfinsight.com
BriaCell Therapeutics Corp. (BCTXZ)
BriaCell Therapeutics Corp. (BCTXZ)